• Info
  • Insider Ownership

Insider Trading & Ownership of Jane Huang

Location
Camana Bay
Summary
The estimated net worth of Jane Huang is at least $33,399,896 dollars as of 07 Oct 2025. Jane Huang is the CMO, Hematology of BeiGene, Ltd. and owns shares of BeiGene, Ltd. (ONC) stock worth about $33.25M. Jane Huang is the President, CMO of Prelude Therapeutics Inc and owns shares of Prelude Therapeutics Inc (PRLD) stock worth about $153.7K.
Signature
/s/ Bryant D. Lim, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Jane Huang files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Jane Huang

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ONC, BEIGF BeiGene, Ltd. CMO, Hematology $33,246,160 14 Dec 2021
PRLD Prelude Therapeutics Inc President, CMO $153,736 04 Oct 2025
TARA Protara Therapeutics, Inc. Director 12 Jun 2025

Insider Transactions Reported by Jane Huang:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.